There are 2789 resources available
906P - Simlukafusp α and cetuximab combination in patients with recurrent, unresectable or metastatic squamous cell carcinoma of the head and neck
Presenter: Aaron Hansen
Session: ePoster Display
907P - Ribociclib and spartalizumab for head and neck squamous cell carcinoma: A phase I study with expansion cohort
Presenter: Hsiang-Fong Kao
Session: ePoster Display
908P - Efficacy and safety of penpulimab plus anlotinib in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): A phase II study
Presenter: Yuan-Kai Shi
Session: ePoster Display
910P - Repurposing pantoprazole in advanced head and neck squamous cell carcinoma: A phase I/II randomized study
Presenter: Vanita Noronha
Session: ePoster Display
912P - Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
Presenter: Viktor Gruenwald
Session: ePoster Display
913P - Apatinib for heavily pretreated recurrent and/or metastatic head and neck squamous cell carcinoma: Updated analysis
Presenter: kunyu yang
Session: ePoster Display
914P - Impact of induction chemotherapy (ICT) in borderline resectable or unresectable locally advanced oral squamous cell carcinoma (OSCC)
Presenter: Divya Kukreja
Session: ePoster Display
915P - Carboplatin in combination with three weekly paclitaxel as first line therapy in patients with recurrent/metastatic head and neck cancers: A regional cancer center experience
Presenter: Pooja Babbar
Session: ePoster Display